Abstract
The reciprocal interaction between the central nervous system and endocrine signals plays a pivotal role in sha** emotional processing and behavioral responses related to anxiety. While the hypothalamic-pituitary-adrenal (HPA) axis is the most extensively studied system in this context, the impact of various steroid and peptide hormones on anxiety behaviors is gaining recognition. This book chapter explores recent advancements concerning the involvement of diverse hormones in anxiety regulation, encompassing hormones associated with the brain stress systems, neuropeptides, neurosteroids, and steroid hormones. Emerging insights from both fundamental research and clinical investigations indicate that these systems might underlie stress-induced alterations in anxiety and anxiety-related behaviors. By broadening the spectrum of mechanisms associated with depression and anxiety, there lies the potential to devise innovative approaches for mitigating stress-related mental health conditions. The systems discussed within this chapter encompass a range of neuroendocrine targets that may help delineate the mechanisms of anxiety disorders as well as identify novel therapeutic targets.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acevedo-Rodriguez, A., Mani, S. K., & Handa, R. J. (2015). Oxytocin and Estrogen Receptor β in the Brain: An Overview. Frontiers in Endocrinology, 6, 160. https://doi.org/10.3389/fendo.2015.00160
Aikey, J. L., Nyby, J. G., Anmuth, D. M., & James, P. J. (2002). Testosterone Rapidly Reduces Anxiety in Male House Mice (Mus musculus). Hormones and Behavior, 42(4), 448–460. https://doi.org/10.1006/hbeh.2002.1838
Akça, Ö. F., Uzun, N., & Kılınç, İ. (2020). Orexin A in adolescents with anxiety disorders. International Journal of Psychiatry in Clinical Practice. https://doi.org/10.1080/13651501.2019.1711425
Andréen, L., Spigset, O., Andersson, A., Nyberg, S., & Bäckström, T. (2006). Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone. Maturitas, 54(3), 238–244. https://doi.org/10.1016/j.maturitas.2005.11.005
Arble, D. M., Copinschi, G., Vitaterna, M. H., Van Cauter, E., & Turek, F. W. (2012). Chapter 12 - Circadian Rhythms in Neuroendocrine Systems (G. Fink, D. W. Pfaff, & J. E. B. T.-H. of N. Levine (eds.); pp. 271–305). Academic Press. https://doi.org/10.1016/B978-0-12-375097-6.10012-5
Arnsten, A. F. T. (2009). Stress signalling pathways that impair prefrontal cortex structure and function. Nature Reviews. Neuroscience, 10(6), 410–422. https://doi.org/10.1038/nrn2648
Bajo, M., Cruz, M. T., Siggins, G. R., Messing, R., & Roberto, M. (2008). Protein kinase C epsilon mediation of CRF- and ethanol-induced GABA release in central amygdala. Proceedings of the National Academy of Sciences of the United States of America, 105(24), 8410–8415. https://doi.org/10.1073/pnas.0802302105
Ballaz, S. J., Bourin, M., Akil, H., & Watson, S. J. (2020). Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 96, 109761. https://doi.org/10.1016/j.pnpbp.2019.109761
Bangasser, D. A., Curtis, A., Reyes, B. A. S., Bethea, T. T., Parastatidis, I., Ischiropoulos, H., Van Bockstaele, E. J., & Valentino, R. J. (2010). Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Molecular Psychiatry, 15(9), 877,896-904. https://doi.org/10.1038/mp.2010.66
Barbaccia, M. L., Serra, M., Purdy, R. H., & Biggio, G. (2001). Stress and neuroactive steroids. International Review of Neurobiology, 46, 243–272. https://doi.org/10.1016/s0074-7742(01)46065-x
Barr, J. L., & Forster, G. L. (2011). Serotonergic neurotransmission in the ventral hippocampus is enhanced by corticosterone and altered by chronic amphetamine treatment. Neuroscience, 182, 105–114. https://doi.org/10.1016/j.neuroscience.2011.03.020
Batelaan, N. M., de Graaf, R., Penninx, B. W. J. H., van Balkom, A. J. L. M., Vollebergh, W. A. M., & Beekman, A. T. F. (2010). The 2-year prognosis of panic episodes in the general population. Psychological Medicine, 40(1), 147–157. https://doi.org/10.1017/S0033291709005625
Baulieu, E.-E. (1981). STEROID HORMONES IN THE BRAIN: SEVERAL MECHANISMS? (K. Fuxe, J.-Å. Gustafsson, & L. B. T.-S. H. R. of the B. Wetterberg (eds.); pp. 3–14). Pergamon. https://doi.org/10.1016/B978-0-08-026864-4.50007-4
Baxter, A. J., Scott, K. M., Vos, T., & Whiteford, H. A. (2013). Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychological Medicine, 43(5), 897–910. https://doi.org/10.1017/S003329171200147X
Berglund, L. H., Prytz, H. S., Perski, A., & Svartberg, J. (2011). Testosterone levels and psychological health status in men from a general population: the Tromsø study. The Aging Male: The Official Journal of the International Society for the Study of the Aging Male, 14(1), 37–41. https://doi.org/10.3109/13685538.2010.522276
Bertholomey, M. L., Nagarajan, V., Smith, D. M., & Torregrossa, M. M. (2022). Sex- and age-dependent effects of chronic corticosterone exposure on depressive-like, anxiety-like, and fear-related behavior: Role of amygdala glutamate receptors in the rat. Frontiers in Behavioral Neuroscience, 16, 950000. https://doi.org/10.3389/fnbeh.2022.950000
Bethlehem, R. A. I., Baron-Cohen, S., van Honk, J., Auyeung, B., & Bos, P. A. (2014). The oxytocin paradox. Frontiers in Behavioral Neuroscience, 8, 48. https://doi.org/10.3389/fnbeh.2014.00048
Bielsky, I. F., Hu, S.-B., Szegda, K. L., Westphal, H., & Young, L. J. (2004). Profound Impairment in Social Recognition and Reduction in Anxiety-Like Behavior in Vasopressin V1a Receptor Knockout Mice. Neuropsychopharmacology, 29(3), 483–493. https://doi.org/10.1038/sj.npp.1300360
Bitran, D., Dugan, M., Renda, P., Ellis, R., & Foley, M. (1999). Anxiolytic effects of the neuroactive steroid pregnanolone (3 alpha-OH-5 beta-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum. Brain Research, 850(1–2), 217–224. https://doi.org/10.1016/s0006-8993(99)02150-2
Bitran, D., Hilvers, R. J., & Kellogg, C. K. (1991). Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Research, 561(1), 157–161. https://doi.org/10.1016/0006-8993(91)90761-j
Boccia, M. L., Petrusz, P., Suzuki, K., Marson, L., & Pedersen, C. A. (2013). Immunohistochemical localization of oxytocin receptors in human brain. Neuroscience, 253, 155–164. https://doi.org/10.1016/j.neuroscience.2013.08.048
Boivin, J. R., Piekarski, D. J., Wahlberg, J. K., & Wilbrecht, L. (2017). Age, sex, and gonadal hormones differently influence anxiety- and depression-related behavior during puberty in mice. Psychoneuroendocrinology, 85, 78–87. https://doi.org/10.1016/j.psyneuen.2017.08.009
Borrow, A. P., Stranahan, A. M., Suchecki, D., & Yunes, R. (2016). Neuroendocrine Regulation of Anxiety: Beyond the Hypothalamic-Pituitary-Adrenal Axis. Journal of Neuroendocrinology, 28(7). https://doi.org/10.1111/jne.12403
Bradwejn, J., Koszycki, D., & Shriqui, C. (1991). Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Archives of General Psychiatry, 48(7), 603–610. https://doi.org/10.1001/archpsyc.1991.01810310021005
Bremner, J. D., Innis, R. B., Southwick, S. M., Staib, L., Zoghbi, S., & Charney, D. S. (2000). Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. The American Journal of Psychiatry, 157(7), 1120–1126. https://doi.org/10.1176/appi.ajp.157.7.1120
Bremner, J. D., Krystal, J. H., Southwick, S. M., & Charney, D. S. (1996). Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse (New York, N.Y.), 23(1), 28–38. https://doi.org/10.1002/(SICI)1098-2396(199605)23:1<28::AID-SYN4>3.0.CO;2-J
Broadbear, J. H., Kabel, D., Tracy, L., & Mak, P. (2014). Oxytocinergic regulation of endogenous as well as drug-induced mood. Pharmacology, Biochemistry, and Behavior, 119, 61–71. https://doi.org/10.1016/j.pbb.2013.07.002
Bruchas, M. R., Land, B. B., Lemos, J. C., & Chavkin, C. (2009). CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior. PloS One, 4(12), e8528. https://doi.org/10.1371/journal.pone.0008528
Bruijnzeel, A. W., Prado, M., & Isaac, S. (2009). Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse. Biological Psychiatry, 66(2), 110–117. https://doi.org/10.1016/j.biopsych.2009.01.010
Bruschetta, G., **, S., Liu, Z.-W., Kim, J. D., & Diano, S. (2020). MC(4)R Signaling in Dorsal Raphe Nucleus Controls Feeding, Anxiety, and Depression. Cell Reports, 33(2), 108267. https://doi.org/10.1016/j.celrep.2020.108267
Bystritsky, A. (2006). Treatment-resistant anxiety disorders. Molecular Psychiatry, 11(9), 805–814. https://doi.org/10.1038/sj.mp.4001852
Caldwell, H. K., Lee, H.-J., Macbeth, A. H., & Young, W. S. 3rd. (2008). Vasopressin: behavioral roles of an “original” neuropeptide. Progress in Neurobiology, 84(1), 1–24. https://doi.org/10.1016/j.pneurobio.2007.10.007
Cameron, O. G., Lee, M. A., Kotun, J., & McPhee, K. M. (1986). Circadian symptom fluctuations in people with anxiety disorders. Journal of Affective Disorders, 11(3), 213–218. https://doi.org/10.1016/0165-0327(86)90072-8
Carrier, N., & Kabbaj, M. (2012). Testosterone and imipramine have antidepressant effects in socially isolated male but not female rats. Hormones and Behavior, 61(5), 678–685. https://doi.org/10.1016/j.yhbeh.2012.03.001
Carrier, N., Saland, S. K., Duclot, F., He, H., Mercer, R., & Kabbaj, M. (2015). The Anxiolytic and Antidepressant-like Effects of Testosterone and Estrogen in Gonadectomized Male Rats. Biological Psychiatry, 78(4), 259–269. https://doi.org/10.1016/j.biopsych.2014.12.024
Carter, R. B., Wood, P. L., Wieland, S., Hawkinson, J. E., Belelli, D., Lambert, J. J., White, H. S., Wolf, H. H., Mirsadeghi, S., Tahir, S. H., Bolger, M. B., Lan, N. C., & Gee, K. W. (1997). Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor. The Journal of Pharmacology and Experimental Therapeutics, 280(3), 1284–1295.
Chaki, S., & Okubo, T. (2007). Melanocortin-4 receptor antagonists for the treatment of depression and anxiety disorders. Current Topics in Medicinal Chemistry, 7(11), 1145–1151. https://doi.org/10.2174/156802607780906618
Chaudhri, O., Small, C., & Bloom, S. (2006). Gastrointestinal hormones regulating appetite. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 361(1471), 1187–1209. https://doi.org/10.1098/rstb.2006.1856
Chen, C. V, Brummet, J. L., Lonstein, J. S., Jordan, C. L., & Breedlove, S. M. (2014). New knockout model confirms a role for androgen receptors in regulating anxiety-like behaviors and HPA response in mice. Hormones and Behavior, 65(3), 211–218. https://doi.org/10.1016/j.yhbeh.2014.01.001
Copperi, F., Kim, J. D., & Diano, S. (2022). Melanocortin Signaling Connecting Systemic Metabolism With Mood Disorders. Biological Psychiatry, 91(10), 879–887. https://doi.org/10.1016/j.biopsych.2021.05.026
Costa, B., Pini, S., Baldwin, D. S., Silove, D., Manicavasagar, V., Abelli, M., Coppedè, F., & Martini, C. (2017). Oxytocin receptor and G-protein polymorphisms in patients with depression and separation anxiety. Journal of Affective Disorders, 218, 365–373. https://doi.org/10.1016/j.jad.2017.03.056
Cutler, A. J., Mattingly, G. W., & Maletic, V. (2023). Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder. Translational Psychiatry, 13(1), 228. https://doi.org/10.1038/s41398-023-02514-2
D’Anna, K. L., Stevenson, S. A., & Gammie, S. C. (2005). Urocortin 1 and 3 impair maternal defense behavior in mice. Behavioral Neuroscience, 119(4), 1061–1071. https://doi.org/10.1037/0735-7044.119.4.1061
Davis, S. A., & St. Amand, C. (2014). Effects of Testosterone Treatment and Chest Reconstruction Surgery on Mental Health and Sexuality in Female-To-Male Transgender People. International Journal of Sexual Health, 26(2), 113–128. https://doi.org/10.1080/19317611.2013.833152
Del Boca, C., Lutz, P. E., Le Merrer, J., Koebel, P., & Kieffer, B. L. (2012). Cholecystokinin knock-down in the basolateral amygdala has anxiolytic and antidepressant-like effects in mice. Neuroscience, 218, 185–195. https://doi.org/10.1016/j.neuroscience.2012.05.022
Dell’Osso, B., Buoli, M., Baldwin, D. S., & Altamura, A. C. (2010). Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy. Human Psychopharmacology, 25(1), 17–29. https://doi.org/10.1002/hup.1074
Demetrio, F. N., Rennó, J. J., Gianfaldoni, A., Gonçalves, M., Halbe, H. W., Filho, A. H. G. V, & Gorenstein, C. (2011). Effect of estrogen replacement therapy on symptoms of depression and anxiety in non-depressive menopausal women: a randomized double-blind, controlled study. Archives of Women’s Mental Health, 14(6), 479–486. https://doi.org/10.1007/s00737-011-0241-3
Desai, S. J., Borkar, C. D., Nakhate, K. T., Subhedar, N. K., & Kokare, D. M. (2014). Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice. Neuroscience, 277, 818–830. https://doi.org/10.1016/j.neuroscience.2014.07.062
do Rego, J. L., Vaudry, D., & Vaudry, H. (2015). The non-benzodiazepine anxiolytic drug etifoxine causes a rapid, receptor-independent stimulation of neurosteroid biosynthesis. PloS One, 10(3), e0120473. https://doi.org/10.1371/journal.pone.0120473
Dore, R., Iemolo, A., Smith, K. L., Wang, X., Cottone, P., & Sabino, V. (2013). CRF mediates the anxiogenic and anti-rewarding, but not the anorectic effects of PACAP. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 38(11), 2160–2169. https://doi.org/10.1038/npp.2013.113
Edinger, K. L., & Frye, C. A. (2006). Intrahippocampal administration of an androgen receptor antagonist, flutamide, can increase anxiety-like behavior in intact and DHT-replaced male rats. Hormones and Behavior, 50(2), 216–222. https://doi.org/10.1016/j.yhbeh.2006.03.003
Egashira, N., Tanoue, A., Higashihara, F., Fuchigami, H., Sano, K., Mishima, K., Fukue, Y., Nagai, H., Takano, Y., Tsujimoto, G., Stemmelin, J., Griebel, G., Iwasaki, K., Ikeda, T., Nishimura, R., & Fujiwara, M. (2005). Disruption of the Prepulse Inhibition of the Startle Reflex in Vasopressin V1b Receptor Knockout Mice: Reversal by Antipsychotic Drugs. Neuropsychopharmacology, 30(11), 1996–2005. https://doi.org/10.1038/sj.npp.1300784
Egashira, N., Tanoue, A., Matsuda, T., Koushi, E., Harada, S., Takano, Y., Tsujimoto, G., Mishima, K., Iwasaki, K., & Fujiwara, M. (2007). Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice. Behavioural Brain Research, 178(1), 123–127. https://doi.org/10.1016/j.bbr.2006.12.009
Engin, E., & Treit, D. (2007). The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus. Behavioural Pharmacology, 18(5–6), 461–470. https://doi.org/10.1097/FBP.0b013e3282d28f6f
Eppolito, A. K., Kodeih, H. R., & Gerak, L. R. (2014). Using drug combinations to assess potential contributions of non-GABAA receptors in the discriminative stimulus effects of the neuroactive steroid pregnanolone in rats. Physiology & Behavior, 137, 33–41. https://doi.org/10.1016/j.physbeh.2014.07.003
Farhane-Medina, N. Z., Luque, B., Tabernero, C., & Castillo-Mayén, R. (2022). Factors associated with gender and sex differences in anxiety prevalence and comorbidity: A systematic review. Science Progress, 105(4), 00368504221135469. https://doi.org/10.1177/00368504221135469
Farooqi, N. A. I., Scotti, M., Lew, J. M., Botteron, K. N., Karama, S., McCracken, J. T., & Nguyen, T.-V. (2018). Role of DHEA and cortisol in prefrontal-amygdalar development and working memory. Psychoneuroendocrinology, 98, 86–94. https://doi.org/10.1016/j.psyneuen.2018.08.010
Feng, Y., Shao, R., Weijdegård, B., Wang, T., Johansson, J., Sun, S., Wang, W., Egecioglu, E., Billig, H., & Stener-Victorin, E. (2011). Effects of androgen and leptin on behavioral and cellular responses in female rats. Hormones and Behavior, 60(4), 427–438. https://doi.org/10.1016/j.yhbeh.2011.07.012
Flood, J. F., Morley, J. E., & Roberts, E. (1992). Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proceedings of the National Academy of Sciences of the United States of America, 89(5), 1567–1571. https://doi.org/10.1073/pnas.89.5.1567
Flood, J. F., Morley, J. E., & Roberts, E. (1995). Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive. Proceedings of the National Academy of Sciences of the United States of America, 92(23), 10806–10810. https://doi.org/10.1073/pnas.92.23.10806
Flores, Á., Valls-Comamala, V., Costa, G., Saravia, R., Maldonado, R., & Berrendero, F. (2014). The hypocretin/orexin system mediates the extinction of fear memories. Neuropsychopharmacology. https://doi.org/10.1038/npp.2014.146
Fosgerau, K., Raun, K., Nilsson, C., Dahl, K., & Wulff, B. S. (2014). Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity. The Journal of Endocrinology, 220(2), 97–107. https://doi.org/10.1530/JOE-13-0284
Friess, E., Tagaya, H., Trachsel, L., Holsboer, F., & Rupprecht, R. (1997). Progesterone-induced changes in sleep in male subjects. The American Journal of Physiology, 272(5 Pt 1), E885-91. https://doi.org/10.1152/ajpendo.1997.272.5.E885
Frye, C A. (2009). Steroids, reproductive endocrine function, and affect. A review. Minerva Ginecologica, 61(6), 541–562.
Frye, Cheryl A, & Edinger, K. L. (2004). Testosterone’s metabolism in the hippocampus may mediate its anti-anxiety effects in male rats. Pharmacology, Biochemistry, and Behavior, 78(3), 473–481. https://doi.org/10.1016/j.pbb.2004.04.019
Frye, Cheryl A, & Walf, A. A. (2002). Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Hormones and Behavior, 41(3), 306–315. https://doi.org/10.1006/hbeh.2002.1763
Fu, L.-Y., & van den Pol, A. N. (2008). Agouti-related peptide and MC3/4 receptor agonists both inhibit excitatory hypothalamic ventromedial nucleus neurons. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 28(21), 5433–5449. https://doi.org/10.1523/JNEUROSCI.0749-08.2008
Furuta, M., Numakawa, T., Chiba, S., Ninomiya, M., Kajiyama, Y., Adachi, N., Akema, T., & Kunugi, H. (2013). Estrogen, Predominantly via Estrogen Receptor α, Attenuates Postpartum-Induced Anxiety- and Depression-Like Behaviors in Female Rats. Endocrinology, 154(10), 3807–3816. https://doi.org/10.1210/en.2012-2136
Gadassi Polack, R., Joormann, J., Orbach, M., Silverman, W. K., & Lebowitz, E. R. (2021). Maternal Depression and Mother-Child Oxytocin Synchrony in Youth with Anxiety Disorders. Research on Child and Adolescent Psychopathology, 49(3), 381–392. https://doi.org/10.1007/s10802-020-00744-2
Gafford, G. M., Guo, J.-D., Flandreau, E. I., Hazra, R., Rainnie, D. G., & Ressler, K. J. (2012). Cell-type specific deletion of GABA(A)α1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction. Proceedings of the National Academy of Sciences of the United States of America, 109(40), 16330–16335. https://doi.org/10.1073/pnas.1119261109
Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., & Iosifescu, D. V. (2020). Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Frontiers in Psychiatry, 11, 595584. https://doi.org/10.3389/fpsyt.2020.595584
Gebert, D., Auer, M. K., Stieg, M. R., Freitag, M. T., Lahne, M., Fuss, J., Schilbach, K., Schopohl, J., Stalla, G. K., & Kopczak, A. (2018). De-masking oxytocin-deficiency in craniopharyngioma and assessing its link with affective function. Psychoneuroendocrinology, 88, 61–69. https://doi.org/10.1016/j.psyneuen.2017.11.006
Georgiou, P., Mou, T.-C. M., Potter, L. E., An, X., Zanos, P., Patton, M. S., Pultorak, K. J., Clark, S. M., Ngyuyen, V., Powels, C. F., Prokai-Tartai, K., Merchenthaler, I., Prokai, L., McCarthy, M. M., Mathur, B. N., & Gould, T. (2022). Estradiol mediates stress-susceptibility in the male brain. BioRxiv, 2022.01.09.475485. https://doi.org/10.1101/2022.01.09.475485
Georgiou, P., Zanos, P., Jenne, C. E., & Gould, T. D. (2019). Sex-specific involvement of estrogen receptors in behavioral responses to stress and psychomotor activation. Frontiers in Psychiatry, 10(FEB), 81. https://doi.org/10.3389/fpsyt.2019.00081
Geracioti, T. D. J., Baker, D. G., Ekhator, N. N., West, S. A., Hill, K. K., Bruce, A. B., Schmidt, D., Rounds-Kugler, B., Yehuda, R., Keck, P. E. J., & Kasckow, J. W. (2001). CSF norepinephrine concentrations in posttraumatic stress disorder. The American Journal of Psychiatry, 158(8), 1227–1230. https://doi.org/10.1176/appi.ajp.158.8.1227
Gerhard, D. (2013). Biological Psychology: An Introduction to Behavioral, Cognitive, and Clinical Neuroscience. In The Yale Journal of Biology and Medicine (Vol. 86, Issue 3, pp. 435–436).
Giltay, E. J., Enter, D., Zitman, F. G., Penninx, B. W. J. H., van Pelt, J., Spinhoven, P., & Roelofs, K. (2012). Salivary testosterone: associations with depression, anxiety disorders, and antidepressant use in a large cohort study. Journal of Psychosomatic Research, 72(3), 205–213. https://doi.org/10.1016/j.jpsychores.2011.11.014
Ginsburg, G. S., Kendall, P. C., Sakolsky, D., Compton, S. N., Piacentini, J., Albano, A. M., Walkup, J. T., Sherrill, J., Coffey, K. A., Rynn, M. A., Keeton, C. P., McCracken, J. T., Bergman, L., Iyengar, S., Birmaher, B., & March, J. (2011). Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS. Journal of Consulting and Clinical Psychology, 79(6), 806–813. https://doi.org/10.1037/a0025933
Girdler, S. S., Straneva, P. A., Light, K. C., Pedersen, C. A., & Morrow, A. L. (2001). Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biological Psychiatry, 49(9), 788–797. https://doi.org/10.1016/s0006-3223(00)01044-1
Gleason, C. E., Dowling, N. M., Wharton, W., Manson, J. E., Miller, V. M., Atwood, C. S., Brinton, E. A., Cedars, M. I., Lobo, R. A., Merriam, G. R., Neal-Perry, G., Santoro, N. F., Taylor, H. S., Black, D. M., Budoff, M. J., Hodis, H. N., Naftolin, F., Harman, S. M., & Asthana, S. (2015). Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study. PLoS Medicine, 12(6), e1001833; discussion e1001833. https://doi.org/10.1371/journal.pmed.1001833
Goekoop, J. G., de Winter, R. P. F., de Rijk, R., Zwinderman, K. H., Frankhuijzen-Sierevogel, A., & Wiegant, V. M. (2006). Depression with above-normal plasma vasopressin: validation by relations with family history of depression and mixed anxiety and retardation. Psychiatry Research, 141(2), 201–211. https://doi.org/10.1016/j.psychres.2005.09.003
Goyal, S. N., Kokare, D. M., Chopde, C. T., & Subhedar, N. K. (2006). Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt’s test in rats. Pharmacology, Biochemistry, and Behavior, 85(2), 369–377. https://doi.org/10.1016/j.pbb.2006.09.004
Grace, S. A., Rossell, S. L., Heinrichs, M., Kordsachia, C., & Labuschagne, I. (2018). Oxytocin and brain activity in humans: A systematic review and coordinate-based meta-analysis of functional MRI studies. Psychoneuroendocrinology, 96, 6–24. https://doi.org/10.1016/j.psyneuen.2018.05.031
Grafe, L. A., & Bhatnagar, S. (2018). Orexins and stress. In Frontiers in Neuroendocrinology. https://doi.org/10.1016/j.yfrne.2018.06.003
Grafe, L. A., Cornfeld, A., Luz, S., Valentino, R., & Bhatnagar, S. (2017). Orexins Mediate Sex Differences in the Stress Response and in Cognitive Flexibility. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2016.10.013
Granger, D. A., Shirtcliff, E. A., Zahn-Waxler, C., Usher, B., Klimes-Dougan, B., & Hastings, P. (2003). Salivary testosterone diurnal variation and psychopathology in adolescent males and females: individual differences and developmental effects. Development and Psychopathology, 15(2), 431–449.
Grider, J. R. (1994). Role of cholecystokinin in the regulation of gastrointestinal motility. The Journal of Nutrition, 124(8 Suppl), 1334S-1339S. https://doi.org/10.1093/jn/124.suppl_8.1334S
Grillon, C., Duncko, R., Covington, M. F., Kopperman, L., & Kling, M. A. (2007). Acute stress potentiates anxiety in humans. Biological Psychiatry, 62(10), 1183–1186. https://doi.org/10.1016/j.biopsych.2007.06.007
Gulyaeva, N. V. (2022). Neuroendocrine Control of Hyperglutamatergic States in Brain Pathologies: the Effects of Glucocorticoids. Journal of Evolutionary Biochemistry and Physiology, 58(5), 1425–1438. https://doi.org/10.1134/S0022093022050131
Gutman, D. A., Owens, M. J., Skelton, K. H., Thrivikraman, K. V, & Nemeroff, C. B. (2003). The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. The Journal of Pharmacology and Experimental Therapeutics, 304(2), 874–880. https://doi.org/10.1124/jpet.102.042788
Hahn, A. C., DeBruine, L. M., Pesce, L. A., Diaz, A., Aberson, C. L., & Jones, B. C. (2020). Does women’s anxious jealousy track changes in steroid hormone levels? Psychoneuroendocrinology, 113, 104553. https://doi.org/10.1016/j.psyneuen.2019.104553
Hang, A., Wang, Y., He, L., & Liu, J. (2015). The role of the dynorphin/κ opioid receptor system in anxiety. Acta Pharmacologica Sinica, 36(7), 783–790. https://doi.org/10.1038/aps.2015.32
Hanukoglu, I., & Jefcoate, C. R. (1980). Pregnenolone separation from cholesterol using Sephadex LH-20 mini-columns. Journal of Chromatography A, 190(1), 256–262. https://doi.org/10.1016/S0021-9673(00)85545-4
Harrewijn, A., Vidal-Ribas, P., Clore-Gronenborn, K., Jackson, S. M., Pisano, S., Pine, D. S., & Stringaris, A. (2020). Associations between brain activity and endogenous and exogenous cortisol - A systematic review. Psychoneuroendocrinology, 120, 104775. https://doi.org/10.1016/j.psyneuen.2020.104775
Hart, D., Nilges, M., Pollard, K., Lynn, T., Patsos, O., Shiel, C., Clark, S. M., & Vasudevan, N. (2014). Activation of the G-protein coupled receptor 30 (GPR30) has different effects on anxiety in male and female mice. Steroids, 81, 49–56. https://doi.org/10.1016/j.steroids.2013.11.004
Hastings, M. H. (1991). Neuroendocrine rhythms. Pharmacology & Therapeutics, 50(1), 35–71. https://doi.org/10.1016/0163-7258(91)90072-T
Heinrichs, S. C., De Souza, E. B., Schulteis, G., Lapsansky, J. L., & Grigoriadis, D. E. (2002). Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 27(2), 194–202. https://doi.org/10.1016/S0893-133X(02)00299-3
Herman, J.P., Flak, J., Jankord, R. (2008). Chronic stress plasticity in the hypothalamic paraventricular nucleus, in: Neumann, I.D., Landgraf, R. (Eds.), Progress in Brain Research. Elsevier, pp. 353–364.
Herman, J. P., McKlveen, J. M., Ghosal, S., Kopp, B., Wulsin, A., Makinson, R., Scheimann, J., & Myers, B. (2016a). Regulation of the Hypothalamic-Pituitary-Adrenocortical Stress Response. Comprehensive Physiology, 6(2), 603–621. https://doi.org/10.1002/cphy.c150015
Herman, M. A., Varodayan, F. P., Oleata, C. S., Luu, G., Kirson, D., Heilig, M., Ciccocioppo, R., & Roberto, M. (2016b). Glutamatergic transmission in the central nucleus of the amygdala is selectively altered in Marchigian Sardinian alcohol-preferring rats: Alcohol and CRF effects. Neuropharmacology, 102, 21–31. https://doi.org/10.1016/j.neuropharm.2015.10.027
Hernando, F., Schoots, O., Lolait, S. J., & Burbach, J. P. (2001). Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin. Endocrinology, 142(4), 1659–1668. https://doi.org/10.1210/endo.142.4.8067
Hodgson, R A, Higgins, G. A., Guthrie, D. H., Lu, S. X., Pond, A. J., Mullins, D. E., Guzzi, M. F., Parker, E. M., & Varty, G. B. (2007). Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression. Pharmacology, Biochemistry, and Behavior, 86(3), 431–440. https://doi.org/10.1016/j.pbb.2006.12.021
Hodgson, Robert A, Mullins, D., Lu, S. X., Guzzi, M., Zhang, X., Bleickardt, C. J., Scott, J. D., Miller, M. W., Stamford, A. W., Parker, E. M., & Varty, G. B. (2014). Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behavior. European Journal of Pharmacology, 730, 157–163. https://doi.org/10.1016/j.ejphar.2014.02.027
Hurlemann, R. (2017). Oxytocin-Augmented Psychotherapy: Beware of Context. Neuropsychopharmacology, 42(1), 377. https://doi.org/10.1038/npp.2016.188
Inutsuka, A., & Yamanaka, A. (2013). The physiological role of orexin/hypocretin neurons in the regulation of sleep/wakefulness and neuroendocrine functions. In Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2013.00018
Ishizuka, Y., Abe, H., Tanoue, A., Kannan, H., & Ishida, Y. (2010). Involvement of vasopressin V1b receptor in anti-anxiety action of SSRI and SNRI in mice. Neuroscience Research, 66(3), 233–237. https://doi.org/10.1016/j.neures.2009.11.004
Jacobson, L. (2014). Hypothalamic-pituitary-adrenocortical axis: neuropsychiatric aspects. Comprehensive Physiology, 4(2), 715–738. https://doi.org/10.1002/cphy.c130036
James, M. H., Campbell, E. J., & Dayas, C. V. (2017). Role of the Orexin/Hypocretin system in stress-related psychiatric disorders. In Current Topics in Behavioral Neurosciences. https://doi.org/10.1007/7854_2016_56
Jenck, F., Moreau, J. L., Martin, J. R., Kilpatrick, G. J., Reinscheid, R. K., Monsma, F. J. J., Nothacker, H. P., & Civelli, O. (1997). Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proceedings of the National Academy of Sciences of the United States of America, 94(26), 14854–14858. https://doi.org/10.1073/pnas.94.26.14854
Ji, G., Fu, Y., Ruppert, K. A., & Neugebauer, V. (2007). Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Molecular Pain, 3, 13. https://doi.org/10.1186/1744-8069-3-13
Ji, G., & Neugebauer, V. (2008). Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors. Journal of Neurophysiology, 99(3), 1201–1212. https://doi.org/10.1152/jn.01148.2007
Jie, F., Yin, G., Yang, W., Yang, M., Gao, S., Lv, J., & Li, B. (2018). Stress in Regulation of GABA Amygdala System and Relevance to Neuropsychiatric Diseases. Frontiers in Neuroscience, 12, 562. https://doi.org/10.3389/fnins.2018.00562
Joëls, M., & Baram, T. Z. (2009). The neuro-symphony of stress. In Nature reviews. Neuroscience (Vol. 10, Issue 6, pp. 459–466). https://doi.org/10.1038/nrn2632
Johnson, P. L., Molosh, A., Fitz, S. D., Arendt, D., Deehan, G. A., Federici, L. M., Bernabe, C., Engleman, E. A., Rodd, Z. A., Lowry, C. A., & Shekhar, A. (2015). Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning. Pharmacology, Biochemistry, and Behavior, 138, 174–179. https://doi.org/10.1016/j.pbb.2015.09.021
Jöhren, O., Neidert, S. J., Kummer, M., & Dominiak, P. (2002). Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus. Peptides. https://doi.org/10.1016/S0196-9781(02)00052-9
Karl, T., Burne, T. H. J., & Herzog, H. (2006). Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety. Behavioural Brain Research, 167(1), 87–93. https://doi.org/10.1016/j.bbr.2005.08.019
Karst, H., Berger, S., Turiault, M., Tronche, F., Schütz, G., & Joëls, M. (2005). Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proceedings of the National Academy of Sciences of the United States of America, 102(52), 19204–19207. https://doi.org/10.1073/pnas.0507572102
Kastenberger, I., Lutsch, C., & Schwarzer, C. (2012). Activation of the G-protein-coupled receptor GPR30 induces anxiogenic effects in mice, similar to oestradiol. Psychopharmacology, 221(3), 527–535. https://doi.org/10.1007/s00213-011-2599-3
Kokane, S. S., & Perrotti, L. I. (2020). Sex Differences and the Role of Estradiol in Mesolimbic Reward Circuits and Vulnerability to Cocaine and Opiate Addiction. Frontiers in Behavioral Neuroscience, 14, 74. https://doi.org/10.3389/fnbeh.2020.00074
Kokare, Dadasaheb M, Dandekar, M. P., Singru, P. S., Gupta, G. L., & Subhedar, N. K. (2010). Involvement of alpha-MSH in the social isolation induced anxiety- and depression-like behaviors in rat. Neuropharmacology, 58(7), 1009–1018. https://doi.org/10.1016/j.neuropharm.2010.01.006
Kokare, Dadasaheb Mahadeo, Dandekar, M. P., Chopde, C. T., & Subhedar, N. (2005). Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats. Brain Research, 1043(1–2), 107–114. https://doi.org/10.1016/j.brainres.2005.02.038
Korosi, A., Veening, J. G., Kozicz, T., Henckens, M., Dederen, J., Groenink, L., van der Gugten, J., Olivier, B., & Roubos, E. W. (2006). Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain. Brain Research, 1072(1), 46–54. https://doi.org/10.1016/j.brainres.2005.12.034
Koshimizu, T., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012). Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiological Reviews, 92(4), 1813–1864. https://doi.org/10.1152/physrev.00035.2011
Krezel, W., Dupont, S., Krust, A., Chambon, P., & Chapman, P. F. (2001). Increased anxiety and synaptic plasticity in estrogen receptor beta -deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 98(21), 12278–12282. https://doi.org/10.1073/pnas.221451898
Krysiak, R., Obuchowicz, E., & Herman, Z. S. (2000). Conditioned fear-induced changes in neuropeptide Y-like immunoreactivity in rats: the effect of diazepam and buspirone. Neuropeptides, 34(3), 148–157. https://doi.org/10.1054/npep.2000.0804
Kudwa, A. E., Bodo, C., Gustafsson, J.-A., & Rissman, E. F. (2005). A previously uncharacterized role for estrogen receptor beta: defeminization of male brain and behavior. Proceedings of the National Academy of Sciences of the United States of America, 102(12), 4608–4612. https://doi.org/10.1073/pnas.0500752102
Laconi, M. R., Chavez, C., Cavicchia, J. C., Fóscolo, M., Sosa, Z., Yunes, R. F., & Cabrera, R. J. (2012). Allopregnanolone alters the luteinizing hormone, prolactin, and progesterone serum levels interfering with the regression and apoptosis in rat corpus luteum. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones et Metabolisme, 44(8), 632–638. https://doi.org/10.1055/s-0032-1314834
Lancaster, K., Goldbeck, L., Pournajafi-Nazarloo, H., Connelly, J. J., Carter, C. S., & Morris, J. P. (2018). The Role of Endogenous Oxytocin in Anxiolysis: Structural and Functional Correlates. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging, 3(7), 618–625. https://doi.org/10.1016/j.bpsc.2017.10.003
Laudisio, A., Antonelli Incalzi, R., Gemma, A., Giovannini, S., Lo Monaco, M. R., Vetrano, D. L., Padua, L., Bernabei, R., & Zuccalà, G. (2018). Use of proton-pump inhibitors is associated with depression: a population-based study. International Psychogeriatrics, 30(1), 153–159. https://doi.org/10.1017/S1041610217001715
Lee, R. S., & Sawa, A. (2014). Environmental stressors and epigenetic control of the hypothalamic-pituitary-adrenal axis. Neuroendocrinology, 100(4), 278–287. https://doi.org/10.1159/000369585
Löfberg, C., Ågren, H., Harro, J., & Oreland, L. (1998). Cholecystokinin in CSF from depressed patients: possible relations to severity of depression and suicidal behaviour. European Neuropsychopharmacology, 8(2), 153–157. https://doi.org/10.1016/S0924-977X(97)00046-1
Longone, P., di Michele, F., D’Agati, E., Romeo, E., Pasini, A., & Rupprecht, R. (2011). Neurosteroids as neuromodulators in the treatment of anxiety disorders. Frontiers in Endocrinology, 2, 55. https://doi.org/10.3389/fendo.2011.00055
Louis, C., Cohen, C., Depoortère, R., & Griebel, G. (2006). Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 31(10), 2180–2187. https://doi.org/10.1038/sj.npp.1301036
Love, T. M. (2018). The impact of oxytocin on stress: the role of sex. Current Opinion in Behavioral Sciences, 23, 136–142. https://doi.org/10.1016/j.cobeha.2018.06.018
Lukkes, J., Vuong, S., Scholl, J., Oliver, H., & Forster, G. (2009). Corticotropin-releasing factor receptor antagonism within the dorsal raphe nucleus reduces social anxiety-like behavior after early-life social isolation. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 29(32), 9955–9960. https://doi.org/10.1523/JNEUROSCI.0854-09.2009
Lund, T. D., Hinds, L. R., & Handa, R. J. (2006). The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 26(5), 1448–1456. https://doi.org/10.1523/JNEUROSCI.3777-05.2006
Lund, T. D., Rovis, T., Chung, W. C. J., & Handa, R. J. (2005). Novel Actions of Estrogen Receptor-β on Anxiety-Related Behaviors. Endocrinology, 146(2), 797–807. https://doi.org/10.1210/en.2004-1158
Lungwitz, E. A., Molosh, A., Johnson, P. L., Harvey, B. P., Dirks, R. C., Dietrich, A., Minick, P., Shekhar, A., & Truitt, W. A. (2012). Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats. Physiology and Behavior. https://doi.org/10.1016/j.physbeh.2012.05.019
Lupien, S. J., McEwen, B. S., Gunnar, M. R., & Heim, C. (2009). Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nature Reviews Neuroscience, 10(6), 434–445. https://doi.org/10.1038/nrn2639
MacDonald, K., & Feifel, D. (2014). Oxytocin’s role in anxiety: a critical appraisal. Brain Research, 1580, 22–56. https://doi.org/10.1016/j.brainres.2014.01.025
Maeng, L. Y., & Milad, M. R. (2015). Sex differences in anxiety disorders: Interactions between fear, stress, and gonadal hormones. Hormones and Behavior, 76, 106–117. https://doi.org/10.1016/j.yhbeh.2015.04.002
Magalhaes, A. C., Holmes, K. D., Dale, L. B., Comps-Agrar, L., Lee, D., Yadav, P. N., Drysdale, L., Poulter, M. O., Roth, B. L., Pin, J.-P., Anisman, H., & Ferguson, S. S. G. (2010). CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling. Nature Neuroscience, 13(5), 622–629. https://doi.org/10.1038/nn.2529
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986). Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science (New York, N.Y.), 232(4753), 1004–1007. https://doi.org/10.1126/science.2422758
Marcus, J. N., Aschkenasi, C. J., Lee, C. E., Chemelli, R. M., Saper, C. B., Yanagisawa, M., & Elmquist, J. K. (2001). Differential expression of Orexin receptors 1 and 2 in the rat brain. Journal of Comparative Neurology. https://doi.org/10.1002/cne.1190
McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation: central role of the brain. Physiological Reviews, 87(3), 873–904. https://doi.org/10.1152/physrev.00041.2006
McEwen, B. S., Gray, J. D., & Nasca, C. (2015). 60 YEARS OF NEUROENDOCRINOLOGY: Redefining neuroendocrinology: stress, sex and cognitive and emotional regulation. The Journal of Endocrinology, 226(2), T67-83. https://doi.org/10.1530/JOE-15-0121
McEwen, B. S., Nasca, C., & Gray, J. D. (2016). Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 41(1), 3–23. https://doi.org/10.1038/npp.2015.171
McLean, C. P., Asnaani, A., Litz, B. T., & Hofmann, S. G. (2011). Gender differences in anxiety disorders: Prevalence, course of illness, comorbidity and burden of illness. Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2011.03.006
Melchior, C. L., & Ritzmann, R. F. (1994). Pregnenolone and pregnenolone sulfate, alone and with ethanol, in mice on the plus-maze. Pharmacology Biochemistry and Behavior, 48(4), 893–897. https://doi.org/10.1016/0091-3057(94)90197-X
Mellman, T. A. (2006). Sleep and anxiety disorders. The Psychiatric Clinics of North America, 29(4), 1047–1058; abstract x. https://doi.org/10.1016/j.psc.2006.08.005
Miguel, T. T., & Nunes-de-Souza, R. L. (2011). Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice. Hormones and Behavior, 60(3), 292–300. https://doi.org/10.1016/j.yhbeh.2011.06.004
Milrod, B., Altemus, M., Gross, C., Busch, F., Silver, G., Christos, P., Stieber, J., & Schneier, F. (2016). Adult separation anxiety in treatment nonresponders with anxiety disorders: delineation of the syndrome and exploration of attachment-based psychotherapy and biomarkers. Comprehensive Psychiatry, 66, 139–145. https://doi.org/10.1016/j.comppsych.2016.01.004
Mineka, S., & Oehlberg, K. (2008). The relevance of recent developments in classical conditioning to understanding the etiology and maintenance of anxiety disorders. Acta Psychologica. https://doi.org/10.1016/j.actpsy.2007.11.007
Mòdol, L., Darbra, S., & Pallarès, M. (2011). Neurosteroids infusion into the CA1 hippocampal region on exploration, anxiety-like behaviour and aversive learning. Behavioural Brain Research, 222(1), 223–229. https://doi.org/10.1016/j.bbr.2011.03.058
Mora, S., Dussaubat, N., & Díaz-Véliz, G. (1996). Effects of the estrous cycle and ovarian hormones on behavioral indices of anxiety in female rats. Psychoneuroendocrinology, 21(7), 609–620. https://doi.org/10.1016/s0306-4530(96)00015-7
Morales-Medina, J. C., Dumont, Y., & Quirion, R. (2010). A possible role of neuropeptide Y in depression and stress. Brain Research, 1314, 194–205. https://doi.org/10.1016/j.brainres.2009.09.077
Morimoto, M., Morita, N., Ozawa, H., Yokoyama, K., & Kawata, M. (1996). Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: an immunohistochemical and in situ hybridization study. Neuroscience Research, 26(3), 235–269. https://doi.org/10.1016/s0168-0102(96)01105-4
Mottolese, R., Redouté, J., Costes, N., Le Bars, D., & Sirigu, A. (2014). Switching brain serotonin with oxytocin. Proceedings of the National Academy of Sciences of the United States of America, 111(23), 8637–8642. https://doi.org/10.1073/pnas.1319810111
Mountjoy, K. G. (2010). Distribution and function of melanocortin receptors within the brain. Advances in Experimental Medicine and Biology, 681, 29–48. https://doi.org/10.1007/978-1-4419-6354-3_3
Mourtzi, N., Sertedaki, A., & Charmandari, E. (2021). Glucocorticoid Signaling and Epigenetic Alterations in Stress-Related Disorders. International Journal of Molecular Sciences, 22(11). https://doi.org/10.3390/ijms22115964
Müller, M. B., Landgraf, R., & Keck, M. E. (2000). Vasopressin, major depression, and hypothalamic-pituitary-adrenocortical desensitization. Biological Psychiatry, 48(4), 330–333. https://doi.org/10.1016/s0006-3223(00)00886-6
Murgatroyd, C., Patchev, A. V, Wu, Y., Micale, V., Bockmühl, Y., Fischer, D., Holsboer, F., Wotjak, C. T., Almeida, O. F. X., & Spengler, D. (2009). Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nature Neuroscience, 12(12), 1559–1566. https://doi.org/10.1038/nn.2436
Muschamp, J. W., Hollander, J. A., Thompson, J. L., Voren, G., Hassinger, L. C., Onvani, S., Kamenecka, T. M., Borgland, S. L., Kenny, P. J., & Carlezon, W. A. (2014). Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proceedings of the National Academy of Sciences of the United States of America. https://doi.org/10.1073/pnas.1315542111
Myers, A. J., Williams, L., Gatt, J. M., McAuley-Clark, E. Z., Dobson-Stone, C., Schofield, P. R., & Nemeroff, C. B. (2014). Variation in the oxytocin receptor gene is associated with increased risk for anxiety, stress and depression in individuals with a history of exposure to early life stress. Journal of Psychiatric Research, 59, 93–100. https://doi.org/10.1016/j.jpsychires.2014.08.021
Natividad, L. A., Buczynski, M. W., Herman, M. A., Kirson, D., Oleata, C. S., Irimia, C., Polis, I., Ciccocioppo, R., Roberto, M., & Parsons, L. H. (2017). Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid Amide Hydrolase Drive an Anxious Phenotype. Biological Psychiatry, 82(7), 500–510. https://doi.org/10.1016/j.biopsych.2017.01.005
Neumann, I. D., & Landgraf, R. (2012). Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends in Neurosciences, 35(11), 649–659. https://doi.org/10.1016/j.tins.2012.08.004
No Title. (n.d.). https://springer.longhoe.net/chapter/10.1007/978-1-4612-1302-4_9
Nuss, P. (2015). Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatric Disease and Treatment, 11, 165–175. https://doi.org/10.2147/NDT.S58841
Nyamugenda, E., Griffin, H., Russell, S., Cooney, K. A., Kowalczyk, N. S., Islam, I., Phelan, K. D., & Baldini, G. (2020). Selective Survival of Sim1/MC4R Neurons in Diet-Induced Obesity. IScience, 23(5), 101114. https://doi.org/10.1016/j.isci.2020.101114
Onodera, M., Ishitobi, Y., Tanaka, Y., Aizawa, S., Masuda, K., Inoue, A., Oshita, H., Okamoto, K., Kawashima, C., Nakanishi, M., Hirakawa, H., Ninomiya, T., Maruyama, Y., Kanehisa, M., Higuma, H., & Akiyoshi, J. (2015). Genetic association of the oxytocin receptor genes with panic, major depressive disorder, and social anxiety disorder. In Psychiatric genetics (Vol. 25, Issue 5, p. 212). https://doi.org/10.1097/YPG.0000000000000096
Oyola, M. G., Portillo, W., Reyna, A., Foradori, C. D., Kudwa, A., Hinds, L., Handa, R. J., & Mani, S. K. (2012). Anxiolytic effects and neuroanatomical targets of estrogen receptor-β (ERβ) activation by a selective ERβ agonist in female mice. Endocrinology, 153(2), 837–846. https://doi.org/10.1210/en.2011-1674
Parris, M. S., Grunebaum, M. F., Galfalvy, H. C., Andronikashvili, A., Burke, A. K., Yin, H., Min, E., Huang, Y.-Y., & Mann, J. J. (2018). Attempted suicide and oxytocin-related gene polymorphisms. Journal of Affective Disorders, 238, 62–68. https://doi.org/10.1016/j.jad.2018.05.022
Paul, S. M., & Purdy, R. H. (1992). Neuroactive steroids. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 6(6), 2311–2322.
Pinnock, S. B., & Herbert, J. (2001). Corticosterone differentially modulates expression of corticotropin releasing factor and arginine vasopressin mRNA in the hypothalamic paraventricular nucleus following either acute or repeated restraint stress. The European Journal of Neuroscience, 13(3), 576–584. https://doi.org/10.1046/j.0953-816x.2000.01406.x
Pleil, K. E., & Skelly, M. J. (2018). CRF modulation of central monoaminergic function: Implications for sex differences in alcohol drinking and anxiety. Alcohol (Fayetteville, N.Y.), 72, 33–47. https://doi.org/10.1016/j.alcohol.2018.01.007
Pomrenze, M. B., Giovanetti, S. M., Maiya, R., Gordon, A. G., Kreeger, L. J., & Messing, R. O. (2019a). Dissecting the Roles of GABA and Neuropeptides from Rat Central Amygdala CRF Neurons in Anxiety and Fear Learning. Cell Reports, 29(1), 13-21.e4. https://doi.org/10.1016/j.celrep.2019.08.083
Pomrenze, M. B., Tovar-Diaz, J., Blasio, A., Maiya, R., Giovanetti, S. M., Lei, K., Morikawa, H., Hopf, F. W., & Messing, R. O. (2019b). A Corticotropin Releasing Factor Network in the Extended Amygdala for Anxiety. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 39(6), 1030–1043. https://doi.org/10.1523/JNEUROSCI.2143-18.2018
Popoli, M., Yan, Z., McEwen, B. S., & Sanacora, G. (2011). The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nature Reviews. Neuroscience, 13(1), 22–37. https://doi.org/10.1038/nrn3138
Raeder, F., Merz, C. J., Margraf, J., & Zlomuzica, A. (2020). The association between fear extinction, the ability to accomplish exposure and exposure therapy outcome in specific phobia. Scientific Reports. https://doi.org/10.1038/s41598-020-61004-3
Reddy, D. S. (2003). Pharmacology of endogenous neuroactive steroids. Critical Reviews in Neurobiology, 15(3–4), 197–234. https://doi.org/10.1615/critrevneurobiol.v15.i34.20
Rehfeld, J. F. (2021). Cholecystokinin and Panic Disorder: Reflections on the History and Some Unsolved Questions. Molecules (Basel, Switzerland), 26(18). https://doi.org/10.3390/molecules26185657
Reis, F. M. C. V, Almada, R. C., Fogaça, M. V, & Brandão, M. L. (2016). Rapid Activation of Glucocorticoid Receptors in the Prefrontal Cortex Mediates the Expression of Contextual Conditioned Fear in Rats. Cerebral Cortex, 26(6), 2639–2649. https://doi.org/10.1093/cercor/bhv103
Reul, J M H M, & Kloet, E. R. D. E. (1985). Two Receptor Systems for Corticosterone in Rat Brain: Microdistribution and Differential Occupation. Endocrinology, 117(6), 2505–2511. https://doi.org/10.1210/endo-117-6-2505
Reul, Johannes M H M, Collins, A., Saliba, R. S., Mifsud, K. R., Carter, S. D., Gutierrez-Mecinas, M., Qian, X., & Linthorst, A. C. E. (2015). Glucocorticoids, epigenetic control and stress resilience. Neurobiology of Stress, 1, 44–59. https://doi.org/10.1016/j.ynstr.2014.10.001
Risbrough, V. B., Hauger, R. L., Pelleymounter, M. A., & Geyer, M. A. (2003). Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology, 170(2), 178–187. https://doi.org/10.1007/s00213-003-1535-6
Risbrough, V. B., & Stein, M. B. (2006). Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Hormones and Behavior, 50(4), 550–561. https://doi.org/10.1016/j.yhbeh.2006.06.019
Roberto, M., Cruz, M. T., Gilpin, N. W., Sabino, V., Schweitzer, P., Bajo, M., Cottone, P., Madamba, S. G., Stouffer, D. G., Zorrilla, E. P., Koob, G. F., Siggins, G. R., & Parsons, L. H. (2010). Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence. Biological Psychiatry, 67(9), 831–839. https://doi.org/10.1016/j.biopsych.2009.11.007
Rocha, A., Godino-Gimeno, A., & Cerdá-Reverter, J. M. (2019). Evolution of proopiomelanocortin. Vitamins and Hormones, 111, 1–16. https://doi.org/10.1016/bs.vh.2019.05.008
Ryan, J., Scali, J., Carrière, I., Scarabin, P.-Y., Ritchie, K., & Ancelin, M.-L. (2011). Estrogen receptor gene variants are associated with anxiety disorders in older women. Psychoneuroendocrinology, 36(10), 1582–1586. https://doi.org/10.1016/j.psyneuen.2011.04.011
Sah, R., Ekhator, N. N., Strawn, J. R., Sallee, F. R., Baker, D. G., Horn, P. S., & Geracioti, T. D. J. (2009). Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biological Psychiatry, 66(7), 705–707. https://doi.org/10.1016/j.biopsych.2009.04.037
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., Arch, J. R. S., Buckingham, R. E., Haynes, A. C., Carr, S. A., Annan, R. S., McNulty, D. E., Liu, W. S., Terrett, J. A., Elshourbagy, N. A., … Yanagisawa, M. (1998). Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. https://doi.org/10.1016/S0092-8674(00)80949-6
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000). How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*. Endocrine Reviews, 21(1), 55–89. https://doi.org/10.1210/edrv.21.1.0389
Sayed, S., Van Dam, N. T., Horn, S. R., Kautz, M. M., Parides, M., Costi, S., Collins, K. A., Iacoviello, B., Iosifescu, D. V, Mathé, A. A., Southwick, S. M., Feder, A., Charney, D. S., & Murrough, J. W. (2018). A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder. International Journal of Neuropsychopharmacology, 21(1), 3–11. https://doi.org/10.1093/ijnp/pyx109
Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Maréchal, P., Pequeux, C., Ansseau, M., & Legros, J. J. (2007). Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology, 32(4), 407–410. https://doi.org/10.1016/j.psyneuen.2007.01.009
Schulz, D. W., Mansbach, R. S., Sprouse, J., Braselton, J. P., Collins, J., Corman, M., Dunaiskis, A., Faraci, S., Schmidt, A. W., Seeger, T., Seymour, P., Tingley, F. D. 3rd, Winston, E. N., Chen, Y. L., & Heym, J. (1996). CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proceedings of the National Academy of Sciences of the United States of America, 93(19), 10477–10482. https://doi.org/10.1073/pnas.93.19.10477
Schüssler, P., Kluge, M., Yassouridis, A., Dresler, M., Held, K., Zihl, J., & Steiger, A. (2008). Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women. Psychoneuroendocrinology, 33(8), 1124–1131. https://doi.org/10.1016/j.psyneuen.2008.05.013
Sciolino, N. R., & Holmes, P. V. (2012). Exercise offers anxiolytic potential: a role for stress and brain noradrenergic-galaninergic mechanisms. Neuroscience and Biobehavioral Reviews, 36(9), 1965–1984. https://doi.org/10.1016/j.neubiorev.2012.06.005
Shiozaki, K., Kawabe, M., Karasuyama, K., Kurachi, T., Hayashi, A., Ataka, K., Iwai, H., Takeno, H., Hayasaka, O., Kotani, T., Komatsu, M., & Inui, A. (2020). Neuropeptide Y deficiency induces anxiety-like behaviours in zebrafish (Danio rerio). Scientific Reports, 10(1), 5913. https://doi.org/10.1038/s41598-020-62699-0
Skelton, K. H., Nemeroff, C. B., Knight, D. L., & Owens, M. J. (2000). Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 20(3), 1240–1248. https://doi.org/10.1523/JNEUROSCI.20-03-01240.2000
Slattery, D. A., & Neumann, I. D. (2010). Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology, 58(1), 56–61. https://doi.org/10.1016/j.neuropharm.2009.06.038
Smadja, C., Ruiz, F., Coric, P., Fournié-Zaluski, M. C., Roques, B. P., & Maldonado, R. (1997). CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalins. Psychopharmacology, 132(3), 227–236. https://doi.org/10.1007/s002130050340
Smith, A. S., Tabbaa, M., Lei, K., Eastham, P., Butler, M. J., Linton, L., Altshuler, R., Liu, Y., & Wang, Z. (2016). Local oxytocin tempers anxiety by activating GABAA receptors in the hypothalamic paraventricular nucleus. Psychoneuroendocrinology, 63, 50–58. https://doi.org/10.1016/j.psyneuen.2015.09.017
Smith, S. S., Gong, Q. H., Hsu, F. C., Markowitz, R. S., ffrench-Mullen, J. M., & Li, X. (1998). GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature, 392(6679), 926–930. https://doi.org/10.1038/31948
Solomon, M. B., Furay, A. R., Jones, K., Packard, A. E. B., Packard, B. A., Wulsin, A. C., & Herman, J. P. (2012). Deletion of forebrain glucocorticoid receptors impairs neuroendocrine stress responses and induces depression-like behavior in males but not females. Neuroscience, 203, 135–143. https://doi.org/10.1016/j.neuroscience.2011.12.014
Spiteri, T., Musatov, S., Ogawa, S., Ribeiro, A., Pfaff, D. W., & Ågmo, A. (2010). The role of the estrogen receptor α in the medial amygdala and ventromedial nucleus of the hypothalamus in social recognition, anxiety and aggression. Behavioural Brain Research, 210(2), 211–220. https://doi.org/10.1016/j.bbr.2010.02.033
Sripada, R. K., Marx, C. E., King, A. P., Rampton, J. C., Ho, S. S., & Liberzon, I. (2013). Allopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits. Biological Psychiatry, 73(11), 1045–1053. https://doi.org/10.1016/j.biopsych.2012.12.008
Staton, C. D., Yaeger, J. D. W., Khalid, D., Haroun, F., Fernandez, B. S., Fernandez, J. S., Summers, B. K., Summers, T. R., Sathyanesan, M., Newton, S. S., & Summers, C. H. (2018). Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2018.09.016
Sternson, S. M., & Atasoy, D. (2014). Agouti-related protein neuron circuits that regulate appetite. Neuroendocrinology, 100(2–3), 95–102. https://doi.org/10.1159/000369072
Strawn, J. R., & Geracioti, T. D. J. (2008). Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depression and Anxiety, 25(3), 260–271. https://doi.org/10.1002/da.20292
Ströhle, A., Holsboer, F., & Rupprecht, R. (2000). Increased ACTH Concentrations Associated with Cholecystokinin Tetrapeptide-Induced Panic Attacks in Patients with Panic Disorder. Neuropsychopharmacology, 22(3), 251–256. https://doi.org/10.1016/S0893-133X(99)00115-3
Taché, Y. (2015). Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia. Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society, 27(1), 1–6. https://doi.org/10.1111/nmo.12495
Taheri, S., Mahmoodi, M., Opacka-Juffry, J., Ghatei, M. A., & Bloom, S. R. (1999). Distribution and quantification of immunoreactive orexin A in rat tissues. FEBS Letters. https://doi.org/10.1016/S0014-5793(99)01030-3
Tasan, R. O., Verma, D., Wood, J., Lach, G., Hörmer, B., de Lima, T. C. M., Herzog, H., & Sperk, G. (2016). The role of Neuropeptide Y in fear conditioning and extinction. Neuropeptides, 55, 111–126. https://doi.org/10.1016/j.npep.2015.09.007
Taylor, H. S., & Manson, J. E. (2011). Update in hormone therapy use in menopause. The Journal of Clinical Endocrinology and Metabolism, 96(2), 255–264. https://doi.org/10.1210/jc.2010-0536
Ten-Blanco, M., Flores, Á., Pereda-Pérez, I., Piscitelli, F., Izquierdo-Luengo, C., Cristino, L., Romero, J., Hillard, C. J., Maldonado, R., Di Marzo, V., & Berrendero, F. (2022). Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1. Biomedicine and Pharmacotherapy. https://doi.org/10.1016/j.biopha.2022.112925
Thorsell, A. (2010). Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety. Experimental Biology and Medicine (Maywood, N.J.), 235(10), 1163–1167. https://doi.org/10.1258/ebm.2010.009331
Tian, J., Kim, S., Heilig, E., & Ruderman, J. V. (2000). Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation. Proceedings of the National Academy of Sciences of the United States of America, 97(26), 14358–14363. https://doi.org/10.1073/pnas.250492197
Tian, Z., Wang, Y., Zhang, N., Guo, Y.-Y., Feng, B., Liu, S.-B., & Zhao, M.-G. (2013). Estrogen receptor GPR30 exerts anxiolytic effects by maintaining the balance between GABAergic and glutamatergic transmission in the basolateral amygdala of ovariectomized mice after stress. Psychoneuroendocrinology, 38(10), 2218–2233. https://doi.org/10.1016/j.psyneuen.2013.04.011
Twede, V., Tartaglia, A. L., Covey, D. F., & Bamber, B. A. (2007). The neurosteroids dehydroepiandrosterone sulfate and pregnenolone sulfate inhibit the UNC-49 GABA receptor through a common set of residues. Molecular Pharmacology, 72(5), 1322–1329. https://doi.org/10.1124/mol.107.034058
Ugale, R. R., Sharma, A. N., Kokare, D. M., Hirani, K., Subhedar, N. K., & Chopde, C. T. (2007). Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats. Brain Research, 1184, 193–201. https://doi.org/10.1016/j.brainres.2007.09.041
Urbanski, H. F. (2011). Role of Circadian Neuroendocrine Rhythms in the Control of Behavior and Physiology. Neuroendocrinology, 93(4), 211–222. https://doi.org/10.1159/000327399
van Honk, J., Peper, J. S., & Schutter, D. J. L. G. (2005). Testosterone reduces unconscious fear but not consciously experienced anxiety: implications for the disorders of fear and anxiety. Biological Psychiatry, 58(3), 218–225. https://doi.org/10.1016/j.biopsych.2005.04.003
Verma, P., Hellemans, K. G. C., Choi, F. Y., Yu, W., & Weinberg, J. (2010). Circadian phase and sex effects on depressive/anxiety-like behaviors and HPA axis responses to acute stress. Physiology & Behavior, 99(3), 276–285. https://doi.org/10.1016/j.physbeh.2009.11.002
Vialou, V., Bagot, R. C., Cahill, M. E., Ferguson, D., Robison, A. J., Dietz, D. M., Fallon, B., Mazei-Robison, M., Ku, S. M., Harrigan, E., Winstanley, C. A., Joshi, T., Feng, J., Berton, O., & Nestler, E. J. (2014). Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of ΔFosB. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 34(11), 3878–3887. https://doi.org/10.1523/JNEUROSCI.1787-13.2014
Vigen, R., O’Donnell, C. I., Barón, A. E., Grunwald, G. K., Maddox, T. M., Bradley, S. M., Barqawi, A., Woning, G., Wierman, M. E., Plomondon, M. E., Rumsfeld, J. S., & Ho, P. M. (2013). Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels. JAMA, 310(17), 1829–1836. https://doi.org/10.1001/jama.2013.280386
Vollebregt, O., Koyama, E., Zai, C. C., Shaikh, S. A., Lisoway, A. J., Kennedy, J. L., & Beitchman, J. H. (2021). Evidence for association of vasopressin receptor 1A promoter region repeat with childhood onset aggression. Journal of Psychiatric Research, 140, 522–528. https://doi.org/10.1016/j.jpsychires.2021.05.062
Vuong, S. M., Oliver, H. A., Scholl, J. L., Oliver, K. M., & Forster, G. L. (2010). Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism. Behavioural Brain Research, 208(1), 278–281. https://doi.org/10.1016/j.bbr.2009.11.036
Walf, A. A., & Frye, C. A. (2005). ERβ-Selective Estrogen Receptor Modulators Produce Antianxiety Behavior when Administered Systemically to Ovariectomized Rats. Neuropsychopharmacology, 30(9), 1598–1609. https://doi.org/10.1038/sj.npp.1300713
Walf, A. A., & Frye, C. A. (2008). Parity and estrogen-administration alter affective behavior of ovariectomized rats. Physiology & Behavior, 93(1–2), 351–356. https://doi.org/10.1016/j.physbeh.2007.09.002
Wang, C., Wang, Q., Ji, B., Pan, Y., Xu, C., Cheng, B., Bai, B., & Chen, J. (2018). The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases. In Frontiers in Molecular Neuroscience. https://doi.org/10.3389/fnmol.2018.00220
Wang, G.-Y., Zhu, Z.-M., Cui, S., & Wang, J.-H. (2016). Glucocorticoid Induces Incoordination between Glutamatergic and GABAergic Neurons in the Amygdala. PloS One, 11(11), e0166535. https://doi.org/10.1371/journal.pone.0166535
Wersinger, S. R., Ginns, E. I., O’Carroll, A.-M., Lolait, S. J., & Young, W. S. 3rd. (2002). Vasopressin V1b receptor knockout reduces aggressive behavior in male mice. Molecular Psychiatry, 7(9), 975–984. https://doi.org/10.1038/sj.mp.4001195
Widerlöv, E., Lindström, L. H., Wahlestedt, C., & Ekman, R. (1988). Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. Journal of Psychiatric Research, 22(1), 69–79. https://doi.org/10.1016/0022-3956(88)90030-1
Wiersielis, K. R., Wicks, B., Simko, H., Cohen, S. R., Khantsis, S., Baksh, N., Waxler, D. E., & Bangasser, D. A. (2016). Sex differences in corticotropin releasing factor-evoked behavior and activated networks. Psychoneuroendocrinology, 73, 204–216. https://doi.org/10.1016/j.psyneuen.2016.07.007
**a, G., Han, Y., Meng, F., He, Y., Srisai, D., Farias, M., Dang, M., Palmiter, R. D., Xu, Y., & Wu, Q. (2021). Reciprocal control of obesity and anxiety-depressive disorder via a GABA and serotonin neural circuit. Molecular Psychiatry, 26(7), 2837–2853. https://doi.org/10.1038/s41380-021-01053-w
Yaeger, J. D. W., Krupp, K. T., Gale, J. J., & Summers, C. H. (2020). Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity. Medicine in Drug Discovery. https://doi.org/10.1016/j.medidd.2020.100059
Yamada, S., Islam, M. S., van Kooten, N., Bovee, S., Oh, Y.-M., Tsujimura, A., Watanabe, Y., & Tanaka, M. (2020). Neuropeptide Y neurons in the nucleus accumbens modulate anxiety-like behavior. Experimental Neurology, 327, 113216. https://doi.org/10.1016/j.expneurol.2020.113216
Yang, Y.-L., Chao, P.-K., & Lu, K.-T. (2006). Systemic and Intra-Amygdala Administration of Glucocorticoid Agonist and Antagonist Modulate Extinction of Conditioned Fear. Neuropsychopharmacology, 31(5), 912–924. https://doi.org/10.1038/sj.npp.1300899
Young, W. S. 3rd, & Gainer, H. (2003). Transgenesis and the study of expression, cellular targeting and function of oxytocin, vasopressin and their receptors. Neuroendocrinology, 78(4), 185–203. https://doi.org/10.1159/000073702
Zheng, H., Lim, J. Y., Kim, Y., Jung, S. T., & Hwang, S. W. (2021). The role of oxytocin, vasopressin, and their receptors at nociceptors in peripheral pain modulation. Frontiers in Neuroendocrinology, 63, 100942. https://doi.org/10.1016/j.yfrne.2021.100942
Ziegler, C., Dannlowski, U., Bräuer, D., Stevens, S., Laeger, I., Wittmann, H., Kugel, H., Dobel, C., Hurlemann, R., Reif, A., Lesch, K.-P., Heindel, W., Kirschbaum, C., Arolt, V., Gerlach, A. L., Hoyer, J., Deckert, J., Zwanzger, P., & Domschke, K. (2015). Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 40(6), 1528–1538. https://doi.org/10.1038/npp.2015.2
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Onisiforou, A., Zanos, P., Georgiou, P. (2024). Neuroendocrine Regulation of Anxiety. In: Charis, C., Panayiotou, G. (eds) Anxiety Disorders and Related Conditions. Springer, Cham. https://doi.org/10.1007/978-3-031-56798-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-031-56798-8_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-56797-1
Online ISBN: 978-3-031-56798-8
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)